Issue 12, 2012

Design, synthesis and biological activity evaluation of regioisomeric spiro-(indoline-isoxazolidines) in the inhibition of TNF-α-induced ICAM-1 expression on human endothelial cells

Abstract

Different regioisomeric spiro-(indoline-isoxazolidines) have been synthesized by the microwave mediated cycloaddition reaction between ethyl(5-fluoro-3-indolylidene)-acetate/ethyl(3-indolylidene)-acetate and the substituted α,N-diphenylnitrones. These compounds were screened for their anti-inflammatory activities through inhibition of TNF-α-induced ICAM-1 expression on human endothelial cells. Spiro-(indoline-isoxazolidine) 9p was found to be the most potent compound in inhibiting the ICAM-1 expression. Furthermore, compound 9p significantly inhibited the adhesion of neutrophils to the endothelium in a concentration-dependent manner and also blocked the translocation of NF-κBp65 subunit from the cytoplasm to the nucleus. We believe that compound 9p could be useful in developing better anti-inflammatory molecules for various inflammatory diseases where NF-κB plays a key role.

Graphical abstract: Design, synthesis and biological activity evaluation of regioisomeric spiro-(indoline-isoxazolidines) in the inhibition of TNF-α-induced ICAM-1 expression on human endothelial cells

Supplementary files

Article information

Article type
Concise Article
Submitted
27 Jul 2012
Accepted
10 Oct 2012
First published
12 Oct 2012

Med. Chem. Commun., 2012,3, 1536-1547

Design, synthesis and biological activity evaluation of regioisomeric spiro-(indoline-isoxazolidines) in the inhibition of TNF-α-induced ICAM-1 expression on human endothelial cells

S. Malhotra, S. Balwani, A. Dhawan, Raunak, Y. Kumar, B. K. Singh, C. E. Olsen, A. K. Prasad, V. S. Parmar and B. Ghosh, Med. Chem. Commun., 2012, 3, 1536 DOI: 10.1039/C2MD20216F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements